$26.50
0.67% yesterday
Nasdaq, Nov 28, 07:00 pm CET

BioLife Solutions, Inc. Stock price

$26.68
-1.36 4.85% 1M
+4.90 22.50% 6M
+0.72 2.77% YTD
-0.38 1.40% 1Y
+6.04 29.26% 3Y
-6.32 19.15% 5Y
+24.49 1,118.26% 10Y
+25.42 2,017.46% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
-0.31 1.15%

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.2b
Net debt
positive
Cash
$79.0m
Shares outstanding
48.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
14.5 | 12.4
EV/Sales
13.7 | 11.7
EV/FCF
negative
P/B
3.6
Financial Health
Equity Ratio
87.3%
Return on Equity
-5.8%
ROCE
-0.3%
ROIC
-0.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$88.8m | $103.4m
EBITDA
$1.1m | $24.3m
EBIT
$-1.0m | $-20.1m
Net Income
$-3.2m | $-17.6m
Free Cash Flow
$-480.0k
Growth (TTM | estimate)
Revenue
-25.0% | 25.7%
EBITDA
105.9% | 653.7%
EBIT
95.2% | -181.4%
Net Income
93.0% | 12.7%
Free Cash Flow
-121.6%
Margin (TTM | estimate)
Gross
70.0%
EBITDA
1.2% | 23.5%
EBIT
-1.2%
Net
-3.6% | -17.0%
Free Cash Flow
-0.5%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
8.6%
Employees
159
Rev per Employee
$520.0k
Show more

Is BioLife Solutions, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

BioLife Solutions, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a BioLife Solutions, Inc. forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
94%
Hold
6%

Financial data from BioLife Solutions, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
89 89
25% 25%
100%
- Direct Costs 27 27
58% 58%
30%
62 62
14% 14%
70%
- Selling and Administrative Expenses 49 49
20% 20%
56%
- Research and Development Expense 8.72 8.72
22% 22%
10%
1.07 1.07
106% 106%
1%
- Depreciation and Amortization 2.11 2.11
42% 42%
2%
EBIT (Operating Income) EBIT -1.04 -1.04
95% 95%
-1%
Net Profit -3.21 -3.21
93% 93%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about BioLife Solutions, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioLife Solutions, Inc. Stock News

Neutral
PRNewsWire
8 days ago
New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation BOTHELL, Wash. , Nov. 20, 2025 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today anno...
Neutral
PRNewsWire
11 days ago
BOTHELL, Wash. , Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management will participate in the following investor conferences during November and December: Raymond James Napa Small Cap Symposium November 17, 2025 Napa Valley at The ...
Neutral
Seeking Alpha
22 days ago
BioLife Solutions, Inc. ( BLFS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Troy Wichterman - Chief Financial Officer Roderick de Greef - CEO & Chairman Conference Call Participants Paul Knight - KeyBanc Capital Markets Inc., Research Division Matthew Stanton - Jefferies LLC, Research Division Steven Etoch - Stephens Inc., Research Division Brendan Smith - TD Cowen,...
More BioLife Solutions, Inc. News

Company Profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 159
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today